Vulnerabilities or disruptions to the global medicine supply chain (including drug shortages) continue to make headlines.
Standards play an important role in the global medicines supply chain, helping governments and manufacturers increase the availability of safe, quality medicines, as well as building patient and health provider trust. In fact, quality standards are a big reason why we in the U.S. can get a prescription filled at our neighborhood pharmacy and trust that the medicine we receive will be safe and work as it should.
Understanding where pharmaceutical KSMs are made can help address vulnerabilities in the medicine supply chain.
Geographic concentration of active pharmaceutical ingredient (API) manufacturing volume shows that US generics come mainly from India, while Europe leads for branded drugs. US tariffs often apply based on where the API was made.
Natural disasters, trade wars and pandemics are just some of the disruptions that the U.S. pharmaceutical supply chain has faced in recent years. Identifying where drug products are made is a first step in characterizing the risk associated with these events. Learn more.
Building on the momentum of recent high-level engagements with health agencies from around the world, USP hosted a delegation from the Republic of Korea’s (South Korea) National Institute of Food and Drug Safety Evaluation (NIFDS) at our U.S. hub in Rockville, MD.
Show 11 More